{"symbol": "IMV", "companyName": "IMV Inc.", "exchange": "NASDAQ Capital Market", "industry": "Biotechnology", "website": "http://www.imvaccine.com", "description": "IMV Inc is a clinical-stage immuno-oncology company. The company is engaged in making immunotherapies more effective, more broadly applicable, and more widely available to people facing cancer and other serious diseases.", "CEO": "Frederic Ors", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}